3000 men join quest to unlock prostate Cancer's secrets

NCT ID NCT06046131

Recruiting now Knowledge-focused Sponsor: Centre Hospitalier Universitaire de la Guadeloupe Source: ClinicalTrials.gov ↗

First seen Jun 25, 2026 · Last updated Jun 27, 2026 · Updated 1 time

Summary

This study is tracking 3000 men with prostate cancer from Guadeloupe and Brittany to understand why the disease progresses differently in different people. Researchers will collect blood, urine, and saliva samples along with health data to look for genetic, environmental, and lifestyle factors that influence cancer growth or return. The goal is to find clues that could help predict outcomes and guide better treatment and prevention.

What this could mean

Our plain-language read of the trial. This is informational only — not medical advice or a prediction.

What this could lead to: If successful, this could identify key risk factors for prostate cancer progression, helping doctors tailor treatments and prevention strategies for high-risk populations.
What could go wrong: This is an observational study, not a treatment trial, so it won't directly benefit participants. Results may take years and might not lead to clear changes in care.

This is an AI summary of the original study and may miss details. Read our disclaimer.

Get updates

Get notified about this study

Sign up to get updates when this study changes or when new studies for ADENOCARCINOMA are added.

Our safety recommendation!

By submitting, you agree to our Terms of use

Conditions

The condition(s) this trial relates to.

adenocarcinoma metastatic neoplasm Neoplasm Metastasis prostate cancer Recurrence

As listed by the trial registrant

The condition terms exactly as the trial's registrant entered them.

ADENOCARCINOMA NEOPLASM METASTASIS NEOPLASM RECURRENCE PROSTATIC NEOPLASM

Contacts and locations

Locations

CHU of Guadeloupe
RECRUITING

Pointe-à-Pitre, Guadeloupe, 97159, Guadeloupe
CHU of Rennes
NOT_YET_RECRUITING

Rennes, Ille-et-Vilaine, 35000, France

More trials for these conditions

Other studies related to the condition(s) this trial covers.